ETFs: Drug Pricing Policy Shapes PPH Risks in 2026
The VanEck PPH ETF faces two key risks in 2026: heavy concentration in Eli Lilly and shifting U.S. drug pricing polic...
Knowing when to sell index funds in a recession helps protect capital and rebalance for future growth. This intro offers timing considerations.
15,106 articlesThe VanEck PPH ETF faces two key risks in 2026: heavy concentration in Eli Lilly and shifting U.S. drug pricing polic...
Stocks trim gains as a risk-on mood cools. The Nasdaq Composite weakens, while tech names temper their rally as trade...
American Express is scrapping its long-standing unit-by-unit bonus race. The company now ties executive pay to overal...
High-income investors face a tax cliff with JEPI: the 8% distribution yield is largely ordinary income, trimming real...
The internet computer (icp) tumbles about 10% in a broad crypto selloff, weakening after Coinbase removed several ICP...
May can bring opportunity for defense stocks as budgets rise and technology drives new capabilities. Here are 3 well-...
As Nvidia prepares to report and guide on May 20, investors weigh the odds of a big move. This article breaks down th...
Analysts debate the odds, but wall street thinks there’s a plausible path to roughly a 20% S&P 500 gain by 2027, driv...
KLAC stock has captured investor attention as semiconductor tool demand shifts with AI and data growth. This guide br...
As the Dow marks its 130th birthday, savvy investors look for steady income and durable growth. Here are three blue c...
A mega-cap AI stock has defied the hype by turning into the unexpected bargain of the Magnificent Seven. Learn what t...
A hidden AI stock is drawing quiet attention. This article breaks down why investors are eyeing it before its next ea...